table	text
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen; Codeine Phosphate, Codeine Phosphate, Diazepam</Other Administered Drugs><Dose></Dose><Adverse Events>Abdominal pain, Cholecystitis, Hepatitis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>50</Age><Age Units>Year</Age Units><Indications>BACK PAIN</Indications>	A 50-year-old male was hospitalized after experiencing abdominal pain, cholecystitis, and hepatitis, which are suspected adverse events from the administration of tramadol hydrochloride, acetaminophen, codeine phosphate, codeine phosphate, and diazepam for the indication of back pain.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Headache, Vomiting projectile</Adverse Events><Outcomes>Disability</Outcomes><Gender>Female</Gender><Age>57</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 57-year-old female experienced disability after taking Tramadol Hydrochloride for pain, reporting adverse events of headache and projectile vomiting.
<Primary Suspect Drugs>Omeprazole</Primary Suspect Drugs><Other Administered Drugs>Heparin Calcium, Pravastatin Sodium, Tramadol Hydrochloride</Other Administered Drugs><Dose>20 MG BID PO</Dose><Adverse Events>Acute generalised exanthematous pustulosis, C-reactive protein increased, Candida infection</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>81</Age><Age Units>Year</Age Units><Indications></Indications>	A female patient, 81 years of age, was hospitalized due to acute generalized exanthematous pustulosis, increased C-reactive protein, and Candida infection. The primary suspect drug was Omeprazole, while other administered drugs included Heparin Calcium, Pravastatin Sodium, and Tramadol Hydrochloride. The patient was taking a dose of 20 MG BID PO.
<Primary Suspect Drugs>Paroxetine Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Diacerein, Nimesulide</Other Administered Drugs><Dose>20MG PER DAY</Dose><Adverse Events>Abdominal pain, Amylase increased, Gamma-glutamyltransferase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>46</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 46-year-old male was hospitalized after experiencing abdominal pain, increased amylase levels, and increased gamma-glutamyltransferase levels possibly due to the use of paroxetine hydrochloride, acetaminophen, diacerein, and nimesulide for an ill-defined disorder.
<Primary Suspect Drugs>Memantine Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Aspirin, Calcium Gluconate, Cetirizine Hydrochloride</Other Administered Drugs><Dose>15 MG QD PO</Dose><Adverse Events>Anaphylactic shock, Cardiac arrest, Cardiac failure</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>79</Age><Age Units>Year</Age Units><Indications>DEMENTIA</Indications>	A 79-year-old female experienced anaphylactic shock, cardiac arrest, and cardiac failure resulting in death after being administered memantine hydrochloride, aspirin, calcium gluconate, and cetirizine hydrochloride for the treatment of dementia.
<Primary Suspect Drugs>Mefenamic Acid</Primary Suspect Drugs><Other Administered Drugs>Clorazepate Dipotassium, Clotiapine, Flurazepam Hydrochloride</Other Administered Drugs><Dose>18G, ONCE, PO</Dose><Adverse Events>Acute kidney injury, Anaemia, Coma</Adverse Events><Outcomes>Hospitalization, LifeThreatening</Outcomes><Gender>Female</Gender><Age>61</Age><Age Units>Year</Age Units><Indications></Indications>	A 61-year-old female experienced acute kidney injury, anemia, and coma after taking Mefenamic Acid with Clorazepate Dipotassium, Clotiapine, and Flurazepam Hydrochloride, resulting in hospitalization and a life-threatening condition.
<Primary Suspect Drugs>Fluoxetine Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Clonazepam, Tramadol Hydrochloride, Trazodone Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Potentiating drug interaction, Serotonin syndrome</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>53</Age><Age Units>Year</Age Units><Indications>DEPRESSION</Indications>	A 53-year-old male patient was hospitalized with serotonin syndrome due to a potentially potentiated drug interaction between fluoxetine hydrochloride and other administered drugs (clonazepam, tramadol hydrochloride, and trazodone hydrochloride) taken orally for the indication of depression.
<Primary Suspect Drugs>Omeprazole</Primary Suspect Drugs><Other Administered Drugs>Abacavir Sulfate, Clarithromycin, Clonazepam</Other Administered Drugs><Dose>20 MG DAILY PO</Dose><Adverse Events>Optic neuropathy, Visual field defect</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>50</Age><Age Units>Year</Age Units><Indications></Indications>	A 50-year-old male was hospitalized after experiencing optic neuropathy and visual field defect, possibly due to the administration of Omeprazole along with Abacavir Sulfate, Clarithromycin, and Clonazepam.
<Primary Suspect Drugs>Omeprazole</Primary Suspect Drugs><Other Administered Drugs>Acebutolol Hydrochloride, Amlodipine Besylate, Cetirizine Hydrochloride</Other Administered Drugs><Dose>40 MG QD PO</Dose><Adverse Events>Abnormal sensation in eye, Angiopathy, Cholestasis</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>62</Age><Age Units>Year</Age Units><Indications>PNEUMONIA KLEBSIELLA</Indications>	A 62-year-old male patient taking Omeprazole 40 mg daily experienced adverse events including abnormal sensation in the eye, angiopathy, and cholestasis. The patient suffered death and required hospitalization. Other administered drugs included Acebutolol Hydrochloride, Amlodipine Besylate, and Cetirizine Hydrochloride. The patient had pneumonia caused by Klebsiella.
<Primary Suspect Drugs>Naratriptan Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetylcysteine, Aspirin, Betamethasone Valerate</Other Administered Drugs><Dose>15MG SINGLE DOSE</Dose><Adverse Events>Somnolence</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>46</Age><Age Units>Year</Age Units><Indications></Indications>	A 46-year-old male was hospitalized after taking a single dose of Naratriptan Hydrochloride, Acetylcysteine, Aspirin, and Betamethasone Valerate, experiencing somnolence as an adverse event.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Cyclobenzaprine Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Ammonia increased, Hepatic failure</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A male was hospitalized after taking tramadol hydrochloride and cyclobenzaprine hydrochloride, resulting in increased ammonia levels and hepatic failure.
<Primary Suspect Drugs>Tacrolimus</Primary Suspect Drugs><Other Administered Drugs>Acebutolol Hydrochloride, Amlodipine Besylate, Cetirizine Hydrochloride</Other Administered Drugs><Dose>2.00 MG, UNKNOWN/D, ORAL</Dose><Adverse Events>Abnormal sensation in eye, Blood alkaline phosphatase increased, Cardiovascular disorder</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>62</Age><Age Units>Year</Age Units><Indications>LIVER TRANSPLANT</Indications>	A 62-year-old male patient who underwent liver transplant experienced adverse events including abnormal sensation in the eye, increased blood alkaline phosphatase, and cardiovascular disorder. Tacrolimus was the primary suspect drug, while Acebutolol Hydrochloride, Amlodipine Besylate, and Cetirizine Hydrochloride were the other administered drugs. The patient's outcomes were death and hospitalization.
<Primary Suspect Drugs>Celecoxib</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Blood pressure systolic increased, Drug ineffective, Hot flush</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>62</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 62-year-old female was hospitalized due to an adverse reaction, including increased blood pressure, ineffectiveness of Celecoxib and Tramadol Hydrochloride, and hot flush, after taking these drugs orally for pain.
<Primary Suspect Drugs>Ferrous Sulfate; Multivitamins</Primary Suspect Drugs><Other Administered Drugs>Aluminum Hydroxide; Magnesium Trisilicate, Cholecalciferol, Iodine</Other Administered Drugs><Dose></Dose><Adverse Events>Foetal cardiac disorder, Ventricular septal defect</Adverse Events><Outcomes>LifeThreatening</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>DRUG EXPOSURE DURING PREGNANCY</Indications>	A male patient experienced a foetal cardiac disorder and ventricular septal defect after exposure to ferrous sulfate, multivitamins, aluminum hydroxide, magnesium trisilicate, cholecalciferol, and iodine during pregnancy, resulting in life-threatening outcomes.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amitriptyline Hydrochloride, Lansoprazole, Spironolactone</Other Administered Drugs><Dose>500 MG</Dose><Adverse Events>Aggression, Deep vein thrombosis, Hallucination</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A female patient was hospitalized after taking Tramadol Hydrochloride, Amitriptyline Hydrochloride, Lansoprazole, and Spironolactone, experiencing aggression, deep vein thrombosis, and hallucinations. The dose of Tramadol Hydrochloride was 500 MG.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Amitriptyline Hydrochloride, Bisoprolol Fumarate</Other Administered Drugs><Dose></Dose><Adverse Events>Acute kidney injury, Bradycardia, Bradypnoea</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>65</Age><Age Units>Year</Age Units><Indications>SCIATICA</Indications>	A 65-year-old female patient with sciatica experienced adverse events, including acute kidney injury, bradycardia, and bradypnoea, after taking Tramadol Hydrochloride along with Acetaminophen, Amitriptyline Hydrochloride, and Bisoprolol Fumarate, resulting in hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Aspirin, Buflomedil, Calcium Carbonate</Other Administered Drugs><Dose></Dose><Adverse Events>Acute kidney injury, Blood creatine phosphokinase increased, Cyanosis</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>81</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	An 81-year-old male patient experienced acute kidney injury, increased blood creatine phosphokinase, and cyanosis as adverse events after being administered Tramadol Hydrochloride, Aspirin, Buflomedil, and Calcium Carbonate. This resulted in death and hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acebutolol Hydrochloride, Enalapril Maleate, Fluindione</Other Administered Drugs><Dose></Dose><Adverse Events>Beta 2 microglobulin increased, Blood immunoglobulin A increased, Blood immunoglobulin G decreased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>80</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	ADE report: An 80-year-old female was hospitalized after taking Tramadol Hydrochloride. Other administered drugs included Acebutolol Hydrochloride, Enalapril Maleate, and Fluindione. Adverse events observed were an increase in Beta 2 microglobulin and Blood immunoglobulin A, and a decrease in Blood immunoglobulin G. The indication for drug use was unknown.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Naproxen, Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Abortion spontaneous, Exposure during pregnancy</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>35</Age><Age Units>Year</Age Units><Indications></Indications>	A 35-year-old female experienced spontaneous abortion and exposure during pregnancy after being administered Tramadol Hydrochloride, Naproxen, and Tramadol Hydrochloride which were the primary and other drugs involved.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Anxiety, Drug dependence, Erectile dysfunction</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>40</Age><Age Units>Year</Age Units><Indications></Indications>	A 40-year-old male experienced adverse events including anxiety, drug dependence, and erectile dysfunction following the administration of Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Toxicity to various agents</Adverse Events><Outcomes>Death</Outcomes><Gender></Gender><Age>55</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 55-year-old individual experienced toxicity to various agents, leading to death, possibly due to tramadol hydrochloride, although other administered drugs are also involved and the indication for drug use is unknown.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Carbamazepine, Clonazepam, Lidocaine</Other Administered Drugs><Dose>200 MG (600 MG, 3 IN 1 D), ORAL</Dose><Adverse Events>Blood alkaline phosphatase increased, Bronchiectasis, Gamma-glutamyltransferase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>74</Age><Age Units>Year</Age Units><Indications>POST HERPETIC NEURALGIA</Indications>	A 74-year-old male was hospitalized after experiencing adverse events including increased blood alkaline phosphatase, bronchiectasis, and increased gamma-glutamyltransferase while taking Gabapentin, Carbamazepine, Clonazepam, and Lidocaine for post-herpetic neuralgia.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Calcium Carbonate, Citalopram Hydrobromide, Perindopril Erbumine</Other Administered Drugs><Dose></Dose><Adverse Events>Blood osmolarity decreased, Blood sodium decreased, Drug interaction</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>PAIN MANAGEMENT</Indications>	A 76-year-old female was hospitalized due to adverse events of decreased blood osmolarity and sodium, as well as a drug interaction, potentially caused by tramadol hydrochloride, calcium carbonate, citalopram hydrobromide, and perindopril erbumine used for pain management.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Prostate cancer</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A male patient's reported adverse event following tramadol hydrochloride administration for unknown indication was death due to prostate cancer.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Headache, Vomiting projectile</Adverse Events><Outcomes>Disability</Outcomes><Gender>Female</Gender><Age>57</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 57-year-old female experienced headache, projectile vomiting, and disability after taking Tramadol Hydrochloride for pain.
<Primary Suspect Drugs>Heparin Sodium</Primary Suspect Drugs><Other Administered Drugs>Clindamycin Hydrochloride, Econazole Nitrate, Floctafenine</Other Administered Drugs><Dose>40 MG (DAILY), SUBCUTANEOUS</Dose><Adverse Events>Eosinophilia, Hepatitis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>42</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 42-year-old male patient was hospitalized after taking Heparin Sodium and experiencing adverse events of Eosinophilia and Hepatitis, while also being administered Clindamycin Hydrochloride, Econazole Nitrate, and Floctafenine for an ill-defined disorder.
<Primary Suspect Drugs>Valacyclovir Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Carbamazepine, Tramadol Hydrochloride</Other Administered Drugs><Dose>500MG THREE TIMES PER DAY</Dose><Adverse Events>Agitation, Anaemia, Aspartate aminotransferase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>40</Age><Age Units>Year</Age Units><Indications>HERPES ZOSTER</Indications>	A 40-year-old male was hospitalized due to agitation, anemia, and increased aspartate aminotransferase after administering Valacyclovir Hydrochloride for the treatment of herpes zoster, alongside Acetaminophen, Carbamazepine, and Tramadol Hydrochloride.
<Primary Suspect Drugs>Acetaminophen</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Atenolol, Carisoprodol</Other Administered Drugs><Dose>PO</Dose><Adverse Events>Acidosis, Alanine aminotransferase increased, Aspartate aminotransferase increased</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Female</Gender><Age>36</Age><Age Units>Year</Age Units><Indications></Indications>	A 36-year-old female was administered Acetaminophen, Atenolol, Carisoprodol orally. This resulted in Acidosis, increased Alanine aminotransferase, increased Aspartate aminotransferase, and led to death and hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Cocaine Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Chest pain, Death, Overdose</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	The primary suspect drug was Tramadol Hydrochloride, and the other administered drug was Cocaine Hydrochloride. The adverse events reported were chest pain, death, and overdose, with death being the outcome. The patient was male and the age and indications were unknown.
<Primary Suspect Drugs>Darbepoetin Alfa</Primary Suspect Drugs><Other Administered Drugs>Interferon Alfa-2a, Recombinant, Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Pyrexia, Staphylococcal bacteraemia, Staphylococcal infection</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>38</Age><Age Units>Year</Age Units><Indications>ANAEMIA OF MALIGNANT DISEASE</Indications>	A 38-year-old female was hospitalized with pyrexia, Staphylococcal bacteraemia, and Staphylococcal infection, believed to be caused by the administration of Darbepoetin Alfa for the treatment of ANAEMIA OF MALIGNANT DISEASE, along with Interferon Alfa-2a, Recombinant, and Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amisulpride, Amitriptyline Hydrochloride, Buprenorphine Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Apraxia, Bronchitis bacterial, General physical health deterioration</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Female</Gender><Age>66</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 66-year-old female experienced adverse events including apraxia, bacterial bronchitis, and general physical health deterioration after being administered tramadol hydrochloride, amisulpride, amitriptyline hydrochloride, and buprenorphine hydrochloride, resulting in hospitalization and death. The drugs were used for unknown indications.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Albuterol, Aspirin</Other Administered Drugs><Dose></Dose><Adverse Events>Coma, Disturbance in attention, Nausea</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>91</Age><Age Units>Year</Age Units><Indications>BACK PAIN</Indications>	A 91-year-old female was hospitalized after experiencing adverse events including coma, disturbance in attention, and nausea, possibly due to the administration of tramadol hydrochloride, acetaminophen, albuterol, and aspirin for the indication of back pain.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amitriptyline Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Drug ineffective, Drug interaction, Serotonin syndrome</Adverse Events><Outcomes>Disability</Outcomes><Gender>Male</Gender><Age>34</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 34-year-old male experienced disability as an outcome of using Tramadol Hydrochloride, Amitriptyline Hydrochloride, resulting in drug ineffectiveness, drug interaction, and serotonin syndrome, although the indication for drug use was unknown.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amlodipine Besylate, Atorvastatin Calcium, Glimepiride</Other Administered Drugs><Dose></Dose><Adverse Events>Confusional state, Drug interaction, Headache</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>53</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 53-year-old male was hospitalized due to adverse events including confusional state, drug interaction, and headache, likely caused by the primary suspect drug Tramadol Hydrochloride, as well as other administered drugs Amlodipine Besylate, Atorvastatin Calcium, and Glimepiride, for the indication of pain.
<Primary Suspect Drugs>Quinapril Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Oedema peripheral, Pain in extremity, Pneumonia</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A female patient possibly died or got hospitalized after taking Quinapril Hydrochloride orally, along with Tramadol Hydrochloride. Adverse events experienced include peripheral edema, extremity pain, and pneumonia, and the patient's condition was related to an ill-defined disorder.
<Primary Suspect Drugs>Lorazepam</Primary Suspect Drugs><Other Administered Drugs>Alcohol, Cocaine Hydrochloride, Tramadol Hydrochloride</Other Administered Drugs><Dose>3.5 MG ONCE PO</Dose><Adverse Events>Drug abuser, Hyperhidrosis, Overdose</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>28</Age><Age Units>Year</Age Units><Indications></Indications>	A 28-year-old male was hospitalized after taking Lorazepam, alcohol, cocaine hydrochloride, and tramadol hydrochloride as well as experiencing drug abuse, hyperhidrosis, and overdose.
<Primary Suspect Drugs>Fentanyl</Primary Suspect Drugs><Other Administered Drugs>Amlodipine Besylate, Baclofen, Fentanyl</Other Administered Drugs><Dose></Dose><Adverse Events>Dyspnoea, Hallucination, Pneumonia aspiration</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A female patient was hospitalized after experiencing dyspnea, hallucinations, and aspiration pneumonia following administration of fentanyl, amlodipine besylate, and baclofen.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>50 MG ORAL</Dose><Adverse Events>Feeling hot, Neuralgia, Tremor</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>61</Age><Age Units>Year</Age Units><Indications>FIBROMYALGIA, MYALGIA</Indications>	A 61-year-old female experienced adverse events including feeling hot, neuralgia, and tremor after taking a 50 MG oral dose of tramadol hydrochloride for fibromyalgia and myalgia.
<Primary Suspect Drugs>Lorazepam</Primary Suspect Drugs><Other Administered Drugs>Bromazepam, Fluindione, Fluoxetine Hydrochloride</Other Administered Drugs><Dose>1 MG Q DAY PO</Dose><Adverse Events>Agitation, Atrial fibrillation, Bundle branch block left</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>81</Age><Age Units>Year</Age Units><Indications>ANXIETY</Indications>	An 81-year-old female with anxiety was hospitalized after experiencing adverse events including agitation, atrial fibrillation, and bundle branch block left, possibly due to the administration of Lorazepam along with Bromazepam, Fluindione, and Fluoxetine Hydrochloride at a daily dose of 1 MG.
<Primary Suspect Drugs>Metaxalone</Primary Suspect Drugs><Other Administered Drugs>Albuterol, Alprazolam, Citalopram Hydrobromide</Other Administered Drugs><Dose>800 MG, UNK</Dose><Adverse Events>Overdose, Toxicity to various agents</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age>34</Age><Age Units>Year</Age Units><Indications>MUSCLE SPASMS</Indications>	The primary suspect drug was Metaxalone, and other administered drugs included Albuterol, Alprazolam, and Citalopram Hydrobromide. The dose of Metaxalone was 800 MG, and the adverse events were an overdose and toxicity to various agents. The outcome was death. The patient was a 34-year-old male, and the indication for the drugs was muscle spasms.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amitriptyline Hydrochloride, Aspirin, Esomeprazole Magnesium</Other Administered Drugs><Dose>1-2 TABLETS EVERY 4-6 HOURS</Dose><Adverse Events>Muscle necrosis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A male patient was hospitalized after experiencing muscle necrosis possibly caused by the administration of Tramadol Hydrochloride, along with Amitriptyline Hydrochloride, Aspirin, and Esomeprazole Magnesium at a dosage of 1-2 tablets every 4-6 hours.
<Primary Suspect Drugs>Citalopram Hydrobromide</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Peginterferon Alfa-2a, Ribavirin</Other Administered Drugs><Dose></Dose><Adverse Events>Angiotensin converting enzyme increased, Arthralgia, Asthenia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>70</Age><Age Units>Year</Age Units><Indications>DEPRESSION</Indications>	A 70-year-old female was hospitalized after experiencing adverse events of increased angiotensin converting enzyme, arthralgia, and asthenia while taking Citalopram Hydrobromide for depression, along with other administered drugs including Acetaminophen, Peginterferon Alfa-2a, and Ribavirin.
<Primary Suspect Drugs>Oxycodone Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Alprazolam, Amitriptyline Hydrochloride, Caffeine Citrate</Other Administered Drugs><Dose></Dose><Adverse Events>Accidental death, Asthenia, Drug abuser</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age>48</Age><Age Units>Year</Age Units><Indications></Indications>	The primary suspect drug in this ADE report is Oxycodone Hydrochloride and the other administered drugs include Alprazolam, Amitriptyline Hydrochloride, and Caffeine Citrate. The reported adverse events are accidental death, asthenia, and drug abuse, with death as the outcome. The patient is a 48-year-old male.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Acetaminophen; Propoxyphene Hydrochloride, Alcohol</Other Administered Drugs><Dose></Dose><Adverse Events>Atrophy, Completed suicide, Decreased activity</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>35</Age><Age Units>Year</Age Units><Indications>MUSCLE SPASMS, PAIN</Indications>	A 35-year-old male reported adverse events including atrophy, completed suicide, and decreased activity after taking gabapentin, acetaminophen, acetaminophen with propoxyphene hydrochloride, and alcohol for muscle spasms and pain. The outcomes were death and hospitalization.
<Primary Suspect Drugs>Peginterferon Alfa-2a</Primary Suspect Drugs><Other Administered Drugs>Amlodipine Besylate, Ammonium Chloride, Lenalidomide</Other Administered Drugs><Dose></Dose><Adverse Events>Depression, Drug ineffective, Insomnia</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>75</Age><Age Units>Year</Age Units><Indications></Indications>	A 75-year-old male experienced depression, drug ineffectiveness, and insomnia after administration of Peginterferon Alfa-2a along with Amlodipine Besylate, Ammonium Chloride, and Lenalidomide.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Piroxicam, Zolmitriptan</Other Administered Drugs><Dose></Dose><Adverse Events>Loss of consciousness</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>25</Age><Age Units>Year</Age Units><Indications></Indications>	A 25-year-old male experienced loss of consciousness after taking Tramadol Hydrochloride, Piroxicam, and Zolmitriptan, resulting in hospitalization.
<Primary Suspect Drugs>Amikacin Sulfate</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Calcium Carbonate, Epoetin Alfa</Other Administered Drugs><Dose></Dose><Adverse Events>Blood alkaline phosphatase increased, Cholestasis, Gamma-glutamyltransferase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>65</Age><Age Units>Year</Age Units><Indications></Indications>	A 65-year-old male was hospitalized after experiencing increased blood alkaline phosphatase, cholestasis, and increased gamma-glutamyltransferase following the administration of amikacin sulfate, acetaminophen, calcium carbonate, and epoetin alfa.
<Primary Suspect Drugs>Amikacin Sulfate</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Calcium Carbonate, Epoetin Alfa</Other Administered Drugs><Dose></Dose><Adverse Events>Blood alkaline phosphatase increased, Cholestasis, Gamma-glutamyltransferase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>65</Age><Age Units>Year</Age Units><Indications></Indications>	A 65-year-old male was hospitalized after experiencing increased blood alkaline phosphatase, cholestasis, and increased gamma-glutamyltransferase due to the administration of amikacin sulfate along with acetaminophen, calcium carbonate, and epoetin alfa.
<Primary Suspect Drugs>Furosemide</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Amikacin Sulfate Liposome, Calcium Carbonate</Other Administered Drugs><Dose></Dose><Adverse Events>Blood alkaline phosphatase increased, Cholestasis, Gamma-glutamyltransferase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>65</Age><Age Units>Year</Age Units><Indications></Indications>	The primary suspect drug in this report is Furosemide, and other administered drugs include Acetaminophen, Amikacin Sulfate Liposome, and Calcium Carbonate. The reported adverse events are increased blood alkaline phosphatase, cholestasis, and increased gamma-glutamyltransferase. The outcome was hospitalization. The patient is a 65-year-old male.
<Primary Suspect Drugs>Diclofenac Sodium</Primary Suspect Drugs><Other Administered Drugs>Felodipine, Glutamine, Simvastatin</Other Administered Drugs><Dose>75 MG/DAY</Dose><Adverse Events>Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood alkaline phosphatase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>NASOPHARYNGITIS</Indications>	A 69-year-old female was hospitalized after taking 75 mg/day of Diclofenac Sodium, Felodipine, Glutamine, and Simvastatin, resulting in increased levels of Alanine aminotransferase, Aspartate aminotransferase, and Blood alkaline phosphatase. The patient's initial indication was nasopharyngitis.
<Primary Suspect Drugs>Mirtazapine</Primary Suspect Drugs><Other Administered Drugs>Bisacodyl, Oxazepam, Phenprocoumon</Other Administered Drugs><Dose>30 MG QD ORAL</Dose><Adverse Events>Drug interaction, Toxicity to various agents</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>AGITATION, CONFUSIONAL STATE, DELIRIUM</Indications>	A 76-year-old female patient who was administered Mirtazapine, Bisacodyl, Oxazepam, and Phenprocoumon experienced drug interaction and toxicity, resulting in death, with the primary indication for these drugs being agitation, confusion, and delirium.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>1-2    3 TIMES DAILY   ORAL</Dose><Adverse Events>Amnesia, Back injury, Seizure</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>29</Age><Age Units>Year</Age Units><Indications>ARTHRALGIA</Indications>	A 29-year-old male experienced amnesia, back injury, and seizure after taking Tramadol Hydrochloride three times a day orally for arthralgia, resulting in hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>ONE PO TID</Dose><Adverse Events>Mobility decreased, Nausea</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>SCOLIOSIS, SPINAL COLUMN STENOSIS</Indications>	A female patient with scoliosis and spinal column stenosis experienced decreased mobility and nausea after taking Tramadol Hydrochloride at a dose of one pill orally three times a day.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Urinary retention</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>30</Age><Age Units>Year</Age Units><Indications></Indications>	A 30-year-old male experienced urinary retention after taking Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Bisacodyl, Mirtazapine, Oxazepam</Other Administered Drugs><Dose></Dose><Adverse Events>Drug interaction, Toxicity to various agents</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 76-year-old female experienced drug interaction, toxicity to various agents, and died after administration of Tramadol Hydrochloride along with Bisacodyl, Mirtazapine, and Oxazepam, for an unknown indication.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acebutolol Hydrochloride, Enalapril Maleate, Fluindione</Other Administered Drugs><Dose></Dose><Adverse Events>Nephrotic syndrome, Proteinuria</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>80</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A female patient aged 80 experienced nephrotic syndrome and proteinuria after being administered Tramadol Hydrochloride, Acebutolol Hydrochloride, Enalapril Maleate, and Fluindione, resulting in hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Cyclobenzaprine Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Ammonia increased, Hepatic failure</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A male patient was hospitalized after experiencing increased ammonia and hepatic failure following the administration of Tramadol Hydrochloride and Cyclobenzaprine Hydrochloride for an unknown indication.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Insulin Lispro (Human Analog), Simvastatin</Other Administered Drugs><Dose>1 TO 2 TABLETS (100MG) DAILY.</Dose><Adverse Events>Hypoglycaemia</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A male patient taking Tramadol Hydrochloride experienced hypoglycemia after taking 1 to 2 tablets (100mg) daily, while also being administered Insulin Lispro (Human Analog) and Simvastatin.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>3 TIMES 20 STROKES.</Dose><Adverse Events>Accidental overdose, Medication error</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A male patient was hospitalized after an accidental overdose and medication error with Tramadol Hydrochloride, administered three times at a dose of 20 strokes. The drug use was for an unknown indication.
<Primary Suspect Drugs>Sulfasalazine</Primary Suspect Drugs><Other Administered Drugs>Acetylcysteine, Budesonide; Formoterol Fumarate, Cefuroxime Axetil</Other Administered Drugs><Dose>2 GRAM (500 MG, 4 IN 1 D), ORAL</Dose><Adverse Events>Abdominal pain upper, Alanine aminotransferase increased, Anaemia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>64</Age><Age Units>Year</Age Units><Indications>RHEUMATOID ARTHRITIS</Indications>	A 64-year-old female with rheumatoid arthritis was hospitalized after experiencing adverse events including upper abdominal pain, increased alanine aminotransferase, and anemia following the administration of sulfasalazine, acetylcysteine, budesonide, formoterol fumarate, and cefuroxime axetil orally at a dose of 2 grams (500 mg, 4 in 1 D).
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Asphyxia, Vomiting</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age>22</Age><Age Units>Year</Age Units><Indications></Indications>	A 22-year-old male died after experiencing adverse events of asphyxia and vomiting, possibly due to the administration of tramadol hydrochloride.
<Primary Suspect Drugs>Furosemide</Primary Suspect Drugs><Other Administered Drugs>Amoxicillin; Clavulanate Potassium, Pantoprazole Sodium, Spiramycin</Other Administered Drugs><Dose></Dose><Adverse Events>Condition aggravated, Purpura non-thrombocytopenic, Respiratory disorder</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>90</Age><Age Units>Year</Age Units><Indications></Indications>	A 90-year-old male experienced aggravated condition, non-thrombocytopenic purpura, and respiratory disorder after being administered Furosemide, Amoxicillin, Clavulanate Potassium, Pantoprazole Sodium, and Spiramycin, resulting in death and hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Enalapril Maleate, Insulin Lispro (Human Analog), Ranitidine</Other Administered Drugs><Dose>50MG BD ORAL</Dose><Adverse Events>Hypoglycaemia</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 69-year-old female patient experienced hypoglycemia after taking Tramadol Hydrochloride (50mg, twice daily orally) along with Enalapril Maleate, Insulin Lispro (Human Analog), and Ranitidine for pain.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Citalopram Hydrobromide, Clonazepam, Ibuprofen</Other Administered Drugs><Dose>600 MG (300 MG, 2 IN 2 D), ORAL</Dose><Adverse Events>Anxiety, Cognitive disorder, Completed suicide</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>60</Age><Age Units>Year</Age Units><Indications>NEUROPATHY PERIPHERAL</Indications>	A 60-year-old male who was taking Gabapentin (600 mg, 2 times daily) for peripheral neuropathy experienced adverse events of anxiety, cognitive disorder, and completed suicide. The outcomes were death and hospitalization. Other administered drugs included Citalopram Hydrobromide, Clonazepam, and Ibuprofen.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Drug abuser</Adverse Events><Outcomes></Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications></Indications>	The primary suspect drug in this ADE report is Tramadol Hydrochloride and the adverse event reported is drug abuse, without any information regarding gender, age, age units, outcomes, other administered drugs, or indications.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>30 DOSE(S), IN 1 DAY, ORAL</Dose><Adverse Events>Drug abuser, Seizure</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>40</Age><Age Units>Year</Age Units><Indications></Indications>	A 40-year-old female experienced drug abuse and a seizure after taking 30 doses of Tramadol Hydrochloride orally in one day.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Drug abuser</Adverse Events><Outcomes></Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications></Indications>	The primary suspect drug in this ADE report is Tramadol Hydrochloride, which was administered orally and resulted in drug abuse adverse events.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Oxycodone Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Drug abuser</Adverse Events><Outcomes></Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications></Indications>	The primary suspect drug was Tramadol Hydrochloride, and Oxycodone Hydrochloride was also administered orally. The adverse event reported was drug abuse. No further information regarding outcomes, gender, age, age units, or indications was provided.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Drug abuser</Adverse Events><Outcomes></Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications></Indications>	The primary suspect drug is Tramadol Hydrochloride, administered orally, resulting in adverse events of drug abuse. No outcomes, gender information, age, age units, or indications were provided.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Escitalopram Oxalate</Other Administered Drugs><Dose>400 MG, IN 1 DAY, ORAL</Dose><Adverse Events>Serotonin syndrome</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>46</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 46-year-old female experienced serotonin syndrome after taking 400 mg of Tramadol Hydrochloride and Escitalopram Oxalate in one day for pain.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Drug abuser, Seizure</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A female drug abuser experienced a seizure after ingesting an oral dose of Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Seizure</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>51</Age><Age Units>Year</Age Units><Indications></Indications>	A 51-year-old female experienced a seizure after taking Tramadol Hydrochloride orally.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amitriptyline Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Seizure</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>51</Age><Age Units>Year</Age Units><Indications></Indications>	A 51-year-old female experienced a seizure after taking Tramadol Hydrochloride as the primary suspect drug, along with Amitriptyline Hydrochloride as another administered drug.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Drug abuser</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>35</Age><Age Units>Year</Age Units><Indications></Indications>	A 35-year-old male drug abuser experienced adverse events from Tramadol Hydrochloride, administered orally.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose>50MG PO Q 6 HRS PRN</Dose><Adverse Events>Abdominal pain, Drug effect decreased, Gastrointestinal disorder</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>54</Age><Age Units>Year</Age Units><Indications>FIBROMYALGIA, OSTEOARTHRITIS</Indications>	A 54-year-old female patient with fibromyalgia and osteoarthritis experienced abdominal pain, decreased drug effect, and gastrointestinal disorder after taking tramadol hydrochloride at a dose of 50mg orally every 6 hours as needed.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>100 MG PO X 1</Dose><Adverse Events>Generalised tonic-clonic seizure, Hypothermia, Somnolence</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>71</Age><Age Units>Year</Age Units><Indications>ARTHRALGIA</Indications>	A 71-year-old male experienced a generalised tonic-clonic seizure, hypothermia, and somnolence after being administered a 100 MG PO dose of Tramadol Hydrochloride for the indication of arthralgia.
<Primary Suspect Drugs>Lorazepam</Primary Suspect Drugs><Other Administered Drugs>Allopurinol, Alprazolam, Diazepam</Other Administered Drugs><Dose>1 MG ONCE PO</Dose><Adverse Events>Accidental overdose, Dehydration, Somnolence</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>91</Age><Age Units>Year</Age Units><Indications></Indications>	A 91-year-old male was hospitalized after an accidental overdose of Lorazepam, along with other administered drugs including Allopurinol, Alprazolam, and Diazepam, resulting in dehydration and somnolence.
<Primary Suspect Drugs>Albendazole</Primary Suspect Drugs><Other Administered Drugs>Amoxicillin; Clavulanate Potassium, Ciprofloxacin Hydrochloride, Tramadol Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Echinococciasis, Haemolysis, Liver disorder</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>46</Age><Age Units>Year</Age Units><Indications>ECHINOCOCCIASIS</Indications>	The 46-year-old female patient was hospitalized due to adverse events of echinococcosis, haemolysis, and liver disorder following the administration of albendazole, amoxicillin, clavulanate potassium, ciprofloxacin hydrochloride, and tramadol hydrochloride.
<Primary Suspect Drugs>Mirtazapine</Primary Suspect Drugs><Other Administered Drugs>Bisacodyl, Oxazepam, Phenprocoumon</Other Administered Drugs><Dose>30 MG QD</Dose><Adverse Events>Drug interaction, Toxicity to various agents</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>DELIRIUM, DEMENTIA</Indications>	A 76-year-old female patient experienced drug interaction and toxicity leading to death after taking Mirtazapine along with Bisacodyl, Oxazepam, and Phenprocoumon for the indications of delirium and dementia.
<Primary Suspect Drugs>Rosiglitazone Maleate</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Calcium Carbonate, Ciprofloxacin Hydrochloride</Other Administered Drugs><Dose>4MG UNKNOWN</Dose><Adverse Events>Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood alkaline phosphatase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>65</Age><Age Units>Year</Age Units><Indications></Indications>	The primary suspect drug in this ADE report is Rosiglitazone Maleate, and other administered drugs include Acetaminophen, Calcium Carbonate, and Ciprofloxacin Hydrochloride. The patient experienced increased levels of alanine aminotransferase, aspartate aminotransferase, and blood alkaline phosphatase, resulting in hospitalization. The patient is a 65-year-old male.
<Primary Suspect Drugs>Bisoprolol Fumarate</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Amoxicillin; Clavulanate Potassium, Aspirin</Other Administered Drugs><Dose>10 MG 1X PER 1 DAY</Dose><Adverse Events>Urticaria</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>54</Age><Age Units>Year</Age Units><Indications></Indications>	A 54-year-old female patient was hospitalized due to urticaria after taking bisoprolol fumarate, acetaminophen, amoxicillin, clavulanate potassium, and aspirin at a dose of 10 MG once per day.
<Primary Suspect Drugs>Cefazolin Sodium</Primary Suspect Drugs><Other Administered Drugs>Acarbose, Alcuronium, Amoxicillin; Clavulanate Potassium</Other Administered Drugs><Dose>2G THREE TIMES PER DAY</Dose><Adverse Events>Blister, Genital erosion, Mucosal erosion</Adverse Events><Outcomes>LifeThreatening</Outcomes><Gender>Female</Gender><Age>63</Age><Age Units>Year</Age Units><Indications>SYSTEMIC ANTIBACTERIAL THERAPY</Indications>	ADE report: A 63-year-old female patient experienced life-threatening adverse events, including blister, genital erosion, and mucosal erosion, after being administered 2G of Cefazolin Sodium three times per day for systemic antibacterial therapy. Additionally, the patient had been given Acarbose, Alcuronium, and Amoxicillin; Clavulanate Potassium.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Rash</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>46</Age><Age Units>Year</Age Units><Indications></Indications>	A 46-year-old male experienced a rash after taking Tramadol Hydrochloride.
<Primary Suspect Drugs>Sertraline Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Drug interaction, Toxicity to various agents</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>35</Age><Age Units>Year</Age Units><Indications>DEPRESSION</Indications>	The primary suspect drug, Sertraline Hydrochloride, and the other administered drug, Tramadol Hydrochloride, were orally taken by a 35-year-old female to treat depression, but resulted in a deadly outcome due to drug interaction and toxicity to various agents.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Aspirin, Clonidine, Esomeprazole Sodium</Other Administered Drugs><Dose></Dose><Adverse Events>Aortic aneurysm, Blood pressure decreased, Electrocardiogram abnormal</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>88</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A male patient, aged 88 years, experienced adverse events including aortic aneurysm, decreased blood pressure, and abnormal electrocardiogram after being administered Tramadol Hydrochloride, Aspirin, Clonidine, and Esomeprazole Sodium.
<Primary Suspect Drugs>Tamsulosin Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Diphenhydramine Hydrochloride, Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Fatigue, Loss of consciousness</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>54</Age><Age Units>Year</Age Units><Indications></Indications>	A 54-year-old male experienced fatigue and loss of consciousness after taking Tamsulosin Hydrochloride, as well as Diphenhydramine Hydrochloride and Tramadol Hydrochloride.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Citalopram Hydrobromide, Tramadol Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Cardio-respiratory arrest, Completed suicide, Overdose</Adverse Events><Outcomes>Death</Outcomes><Gender></Gender><Age>35</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 35-year-old individual experienced cardio-respiratory arrest, completed suicide, and overdose resulting in death after taking Gabapentin, Citalopram Hydrobromide, and Tramadol Hydrochloride for an ill-defined disorder.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amitriptyline Hydrochloride, Terbinafine Hydrochloride</Other Administered Drugs><Dose>100MG PO  TID</Dose><Adverse Events>Anticonvulsant drug level below therapeutic, Generalised tonic-clonic seizure</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>71</Age><Age Units>Year</Age Units><Indications>ARTHRALGIA</Indications>	A 71-year-old male was hospitalized after experiencing a generalised tonic-clonic seizure due to a low anticonvulsant drug level while being administered Tramadol Hydrochloride (100mg PO TID), along with Amitriptyline Hydrochloride and Terbinafine Hydrochloride for arthralgia.
<Primary Suspect Drugs>Morphine Sulfate</Primary Suspect Drugs><Other Administered Drugs>Methadone Hydrochloride, Quinine Sulfate, Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Accidental overdose, Apnoea, Brain oedema</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>53</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 53-year-old female accidentally overdosed on morphine sulfate, methadone hydrochloride, quinine sulfate, and tramadol hydrochloride, resulting in apnoea, brain oedema, and subsequently death.
<Primary Suspect Drugs>Citalopram Hydrobromide</Primary Suspect Drugs><Other Administered Drugs>Gabapentin, Metoclopramide Hydrochloride, Omeprazole</Other Administered Drugs><Dose></Dose><Adverse Events>Cardiac arrest, Coma, Completed suicide</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>35</Age><Age Units>Year</Age Units><Indications></Indications>	A 35-year-old female experienced cardiac arrest, coma, and completed suicide resulting in death after taking Citalopram Hydrobromide as the primary suspect drug, along with Gabapentin, Metoclopramide Hydrochloride, and Omeprazole.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Candesartan Cilexetil, Folic Acid</Other Administered Drugs><Dose></Dose><Adverse Events>Drug interaction, Haematemesis, Iron deficiency anaemia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>77</Age><Age Units>Year</Age Units><Indications></Indications>	A 77-year-old female was hospitalized due to drug interaction, haematemesis, and iron deficiency anaemia, possibly caused by Tramadol Hydrochloride with other administered drugs including Acetaminophen, Candesartan Cilexetil, and Folic Acid.
<Primary Suspect Drugs>Sertraline Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Alprazolam, Donepezil Hydrochloride, Labetalol Hydrochloride</Other Administered Drugs><Dose>50 MG (1 IN 1 D), ORAL</Dose><Adverse Events>Abdominal pain, Abnormal behaviour, Anxiety</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 69-year-old female was hospitalized after experiencing abdominal pain, abnormal behavior, and anxiety following the administration of Sertraline Hydrochloride, Alprazolam, Donepezil Hydrochloride, and Labetalol Hydrochloride for an ill-defined disorder.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Bupropion Hydrochloride, Methylphenidate, Nabumetone</Other Administered Drugs><Dose>2 TID</Dose><Adverse Events>Generalised tonic-clonic seizure</Adverse Events><Outcomes>RequiredIntervention</Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>ANKLE FRACTURE</Indications>	A female patient experienced a generalized tonic-clonic seizure after taking Tramadol Hydrochloride, Bupropion Hydrochloride, Methylphenidate, and Nabumetone at a dose of 2 times per day for the treatment of an ankle fracture.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>100 PO Q 4-8 HR</Dose><Adverse Events>Seizure, Tongue biting</Adverse Events><Outcomes>RequiredIntervention</Outcomes><Gender>Male</Gender><Age>56</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 56-year-old male experienced a seizure and tongue biting after taking Tramadol Hydrochloride for pain, requiring intervention.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Glyburide, Heparin Sodium, Nicoumalone</Other Administered Drugs><Dose></Dose><Adverse Events>Dyspnoea, Fatigue, Hyperhidrosis</Adverse Events><Outcomes>LifeThreatening</Outcomes><Gender>Male</Gender><Age>76</Age><Age Units>Year</Age Units><Indications></Indications>	A 76-year-old male experienced dyspnoea, fatigue, hyperhidrosis, and a life-threatening outcome after taking Tramadol Hydrochloride, Glyburide, Heparin Sodium, and Nicoumalone.
<Primary Suspect Drugs>Fosinopril Sodium</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose>10 MG DAILY</Dose><Adverse Events>Drug hypersensitivity, Swelling face</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>58</Age><Age Units>Year</Age Units><Indications></Indications>	A 58-year-old male experienced drug hypersensitivity and facial swelling after taking Fosinopril Sodium and Tramadol Hydrochloride at a daily dose of 10 MG.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Atropine, Methohexital Sodium, Sevoflurane</Other Administered Drugs><Dose>7 MG, SINGLE, INTRAVENOUS</Dose><Adverse Events>Anticholinergic syndrome</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>6</Age><Age Units>Week</Age Units><Indications>INDUCTION OF ANAESTHESIA</Indications>	A 6-week-old male patient was hospitalized after experiencing anticholinergic syndrome following the administration of Tramadol Hydrochloride, Atropine, Methohexital Sodium, and Sevoflurane for the induction of anesthesia.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>50 MG Q3H</Dose><Adverse Events>Generalised tonic-clonic seizure</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender></Gender><Age>26</Age><Age Units>Year</Age Units><Indications>POST PROCEDURAL PAIN</Indications>	A 26 year old patient was hospitalized after experiencing a generalised tonic-clonic seizure following the administration of Tramadol Hydrochloride for post procedural pain.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen; Codeine Phosphate, Aspirin, Atorvastatin Calcium</Other Administered Drugs><Dose>100MG   ONCE   ORAL</Dose><Adverse Events>Seizure</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>47</Age><Age Units>Year</Age Units><Indications>NECK PAIN</Indications>	A 47-year-old male was hospitalized after experiencing a seizure following the administration of Tramadol Hydrochloride and other drugs including Acetaminophen, Codeine Phosphate, Aspirin, and Atorvastatin Calcium for the treatment of neck pain.
<Primary Suspect Drugs>Naratriptan Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetylcysteine, Aspirin, Betamethasone Valerate</Other Administered Drugs><Dose>15MG SINGLE DOSE</Dose><Adverse Events>Somnolence</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>46</Age><Age Units>Year</Age Units><Indications></Indications>	A 46-year-old male was hospitalized after experiencing somnolence following the administration of naratriptan hydrochloride, acetylcysteine, aspirin, and betamethasone valerate, each for a single dose of 15mg.
<Primary Suspect Drugs>Baclofen</Primary Suspect Drugs><Other Administered Drugs>Aspirin, Calcium Carbonate, Clonidine</Other Administered Drugs><Dose>10 MG TID</Dose><Adverse Events>Mental status changes</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>73</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 73-year-old male was administered Baclofen at a dose of 10 MG TID and experienced mental status changes, leading to hospitalization. Other drugs administered included Aspirin, Calcium Carbonate, and Clonidine for the indication of pain.
<Primary Suspect Drugs>Sertraline Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Candesartan Cilexetil, Esomeprazole Sodium</Other Administered Drugs><Dose>50 MG (50 MG, 1 IN 1 D), ORAL</Dose><Adverse Events>Arthralgia, Haematemesis, Hiatus hernia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>DEPRESSION</Indications>	A female patient experienced arthralgia, haematemesis, and hiatus hernia after taking a 50 mg dose of sertraline hydrochloride for depression. She was subsequently hospitalized.
<Primary Suspect Drugs>Sertraline Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Drug interaction, Toxicity to various agents</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>35</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 35-year-old female died after experiencing drug interaction and toxicity due to the administration of Sertraline Hydrochloride and Tramadol Hydrochloride for an ill-defined disorder.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Celecoxib, Dextromethorphan Polistirex</Other Administered Drugs><Dose>150 MG, Q DAY</Dose><Adverse Events>Abdominal tenderness, Bowel movement irregularity, Colitis ischaemic</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>46</Age><Age Units>Year</Age Units><Indications>BACK PAIN</Indications>	A 46-year-old male was hospitalized after experiencing abdominal tenderness, irregular bowel movements, and ischemic colitis potentially due to the administration of Tramadol Hydrochloride with other drugs including Acetaminophen, Celecoxib, and Dextromethorphan Polistirex for the indication of back pain, at a dose of 150 MG per day.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Cervical vertebral fracture, Loss of consciousness, Seizure</Adverse Events><Outcomes>Disability, Hospitalization</Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A female patient experienced a cervical vertebral fracture, loss of consciousness, and seizure after taking Tramadol Hydrochloride for an unknown indication; resulting in disability and hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Heparin Sodium, Ondansetron</Other Administered Drugs><Dose>720 MG, POSTOPERATIVE</Dose><Adverse Events>Blood pressure systolic increased, Cyanosis, Drug ineffective</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 76-year-old male was administered Tramadol Hydrochloride (primary suspect drug), along with Heparin Sodium and Ondansetron, postoperatively at a dose of 720MG, which resulted in adverse events of increased systolic blood pressure, cyanosis, and drug ineffectiveness, leading to hospitalization.
<Primary Suspect Drugs>Docetaxel</Primary Suspect Drugs><Other Administered Drugs>Cisplatin, Dexamethasone, Fentanyl</Other Administered Drugs><Dose></Dose><Adverse Events>Inflammation, Performance status decreased, Pupillary disorder</Adverse Events><Outcomes>Disability</Outcomes><Gender>Male</Gender><Age>19</Age><Age Units>Year</Age Units><Indications>METASTASIS, NEOPLASM MALIGNANT</Indications>	A 19-year-old male received Docetaxel, Cisplatin, Dexamethasone, and Fentanyl. He experienced inflammation, decreased performance status, and pupillary disorder as adverse events. The outcome was disability. The indications for the treatment were metastasis and malignant neoplasm.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>50 MG</Dose><Adverse Events>Nausea, Therapeutic product ineffective</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>45</Age><Age Units>Year</Age Units><Indications>ARTHROPATHY</Indications>	A 45-year-old female experienced nausea and therapeutic product ineffectiveness after taking 50 MG of Tramadol Hydrochloride for arthropathy.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Heparin Sodium, Ondansetron Hydrochloride</Other Administered Drugs><Dose>SEE IMAGE</Dose><Adverse Events>Medication error, Overdose, Vocal cord disorder</Adverse Events><Outcomes>LifeThreatening, RequiredIntervention</Outcomes><Gender>Male</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>POST PROCEDURAL PAIN</Indications>	A 76-year-old male experienced medication error and overdose after being administered Tramadol Hydrochloride, Heparin Sodium, and Ondansetron Hydrochloride for post-procedural pain, resulting in life-threatening outcomes. The patient also developed vocal cord disorder, requiring intervention.
<Primary Suspect Drugs>Triptorelin Pamoate</Primary Suspect Drugs><Other Administered Drugs>Cyclophosphamide, Danazol, Hydrocortisone</Other Administered Drugs><Dose>3 MG/28 DAYS, INTRAMUSCULAR</Dose><Adverse Events>Cardiomyopathy, Pulmonary oedema, Rheumatoid arthritis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>66</Age><Age Units>Year</Age Units><Indications></Indications>	A 66-year-old female was administered triptorelin pamoate at a dose of 3 mg/28 days intramuscularly, along with cyclophosphamide, danazol, and hydrocortisone. She experienced adverse events including cardiomyopathy, pulmonary edema, and rheumatoid arthritis, resulting in hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Celecoxib, Dextromethorphan Hydrobromide</Other Administered Drugs><Dose>150 MG, DAILY, ORAL</Dose><Adverse Events>Colitis ischaemic, Drug interaction, Potentiating drug interaction</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>46</Age><Age Units>Year</Age Units><Indications>BACK PAIN</Indications>	A 46-year-old male was hospitalized due to colitis ischaemic and drug interactions, potentially caused by the primary suspect drug Tramadol Hydrochloride, as well as other administered drugs including Acetaminophen, Celecoxib, and Dextromethorphan Hydrobromide, taken orally at a daily dose of 150 MG for the indication of back pain.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Feeling abnormal, Therapeutic response decreased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>57</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 57-year-old female was hospitalized after experiencing feeling abnormal and a decrease in therapeutic response due to the administration of Tramadol Hydrochloride for an unknown indication.
<Primary Suspect Drugs>Sertraline Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Donepezil Hydrochloride, Labetalol Hydrochloride, Memantine Hydrochloride</Other Administered Drugs><Dose>50 MG (1 IN 1 D), ORAL</Dose><Adverse Events>Abdominal pain, Abnormal behaviour, Agitation</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 69-year-old female was hospitalized due to abdominal pain, abnormal behavior, and agitation after taking Sertraline Hydrochloride, Donepezil Hydrochloride, Labetalol Hydrochloride, and Memantine Hydrochloride orally.
<Primary Suspect Drugs>Diclofenac Sodium</Primary Suspect Drugs><Other Administered Drugs>Felodipine, Glutamine, Simvastatin</Other Administered Drugs><Dose>75 MG/DAY</Dose><Adverse Events>Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood alkaline phosphatase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>NASOPHARYNGITIS</Indications>	A 69-year-old female was hospitalized after taking 75mg/day of diclofenac sodium, which resulted in increased alanine aminotransferase, aspartate aminotransferase, and blood alkaline phosphatase levels. Other administered drugs included felodipine, glutamine, and simvastatin for the indication of nasopharyngitis.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Heparin Sodium, Ondansetron</Other Administered Drugs><Dose>0.4MG/KG/HR INTRAVENOUS</Dose><Adverse Events>Blood pressure systolic increased, Cyanosis, Drug ineffective</Adverse Events><Outcomes>Hospitalization, LifeThreatening</Outcomes><Gender>Male</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 76-year-old male was hospitalized with life-threatening outcomes after being administered Tramadol Hydrochloride, Heparin Sodium, and Ondansetron intravenously, experiencing adverse events of increased systolic blood pressure, cyanosis, and drug ineffectiveness, for the indication of pain.
<Primary Suspect Drugs>Sertraline Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Alprazolam, Donepezil Hydrochloride, Labetalol Hydrochloride</Other Administered Drugs><Dose>50 MG (MG, 1 IN 1 D),  ORAL</Dose><Adverse Events>Abdominal pain, Abnormal behaviour, Agitation</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 69-year-old female was hospitalized after experiencing abdominal pain, abnormal behavior, and agitation following the administration of sertraline hydrochloride, alprazolam, donepezil hydrochloride, and labetalol hydrochloride in an oral dose of 50 mg.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Carisoprodol, Diazepam, Oxycodone Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Drug dependence, Overdose</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>52</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 52-year-old male experienced drug dependence and overdose after ingesting Tramadol Hydrochloride along with Carisoprodol, Diazepam, and Oxycodone Hydrochloride for an unknown indication.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Cyclophosphamide, Danazol, Prednisone</Other Administered Drugs><Dose></Dose><Adverse Events>Cardiomyopathy, Pulmonary oedema</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>66</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 66-year-old female was hospitalized after experiencing cardiomyopathy and pulmonary edema following the administration of Tramadol Hydrochloride, Cyclophosphamide, Danazol, and Prednisone for unknown indications.
<Primary Suspect Drugs>Candesartan Cilexetil; Hydrochlorothiazide</Primary Suspect Drugs><Other Administered Drugs>Indapamide, Meloxicam, Tramadol Hydrochloride</Other Administered Drugs><Dose>1 DF DAILY PO</Dose><Adverse Events>Confusional state, Disorientation, Hyponatraemia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>85</Age><Age Units>Year</Age Units><Indications>ESSENTIAL HYPERTENSION</Indications>	An 85-year-old male with essential hypertension was administered Candesartan Cilexetil and Hydrochlorothiazide (primary suspect drugs) orally once daily. He also received Indapamide, Meloxicam, and Tramadol Hydrochloride. As a result, he experienced a confusional state, disorientation, and hyponatraemia, leading to hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Levothyroxine Sodium, Tolterodine Tartrate</Other Administered Drugs><Dose></Dose><Adverse Events>Agitation, Disorientation, Emotional distress</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>ARTHRITIS, BACK PAIN</Indications>	A female patient was hospitalized due to adverse events of agitation, disorientation, and emotional distress, after taking tramadol hydrochloride and other administered drugs including levothyroxine sodium and tolterodine tartrate for arthritis and back pain.
<Primary Suspect Drugs>Fentanyl</Primary Suspect Drugs><Other Administered Drugs>Fentanyl, Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Anxiety, Cachexia, Constipation</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age>64</Age><Age Units>Year</Age Units><Indications>ABDOMINAL PAIN UPPER</Indications>	A 64-year-old male received Fentanyl and Tramadol Hydrochloride for ABDOMINAL PAIN UPPER, experiencing Anxiety, Cachexia, Constipation, and ultimately resulting in Death.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Atorvastatin Calcium, Fluconazole, Hydrochlorothiazide</Other Administered Drugs><Dose></Dose><Adverse Events>Hyperkalaemia, Hyponatraemia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>83</Age><Age Units>Year</Age Units><Indications></Indications>	An 83-year-old female was hospitalized due to hyperkalaemia and hyponatraemia, possibly caused by Tramadol Hydrochloride, Atorvastatin Calcium, Fluconazole, and Hydrochlorothiazide.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Respiratory depression, Somnolence, Toxicity to various agents</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>9</Age><Age Units>Month</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 9-month-old male was hospitalized due to respiratory depression, somnolence, and toxicity to various agents resulting from the administration of Tramadol Hydrochloride, a drug used for an unknown indication.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Esomeprazole Sodium, Leucovorin Calcium, Levothyroxine Sodium</Other Administered Drugs><Dose></Dose><Adverse Events>Asthenia, Dysarthria, Headache</Adverse Events><Outcomes>Disability</Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A female patient experienced asthenia, dysarthria, and headache after being administered Tramadol Hydrochloride, Esomeprazole Sodium, Leucovorin Calcium, and Levothyroxine Sodium, resulting in disability.
<Primary Suspect Drugs>Propofol</Primary Suspect Drugs><Other Administered Drugs>Dolasetron Mesylate, Fentanyl Citrate, Tramadol Hydrochloride</Other Administered Drugs><Dose>1 G DAILY IV</Dose><Adverse Events>Mental status changes postoperative, Post procedural complication, Seizure</Adverse Events><Outcomes>RequiredIntervention</Outcomes><Gender>Female</Gender><Age>30</Age><Age Units>Year</Age Units><Indications></Indications>	A 30-year-old female patient experienced mental status changes, postoperative complications, and seizure after receiving Propofol, Dolasetron Mesylate, Fentanyl Citrate, and Tramadol Hydrochloride intravenously at a daily dose of 1g. The patient required intervention.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Drug dependence</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>SURGERY</Indications>	A female patient undergoing surgery experienced drug dependence as an adverse event, with the primary suspect drug being Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>No adverse event</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>15</Age><Age Units>Year</Age Units><Indications></Indications>	A 15-year-old male patient was administered Tramadol Hydrochloride with no adverse events reported in an ADE report.
<Primary Suspect Drugs>Imatinib Mesylate</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Aggression, Confusional state, Drug interaction</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A female patient experienced aggression, confusional state, and drug interaction while taking Imatinib Mesylate and Tramadol Hydrochloride.
<Primary Suspect Drugs>Carbamazepine</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Tramadol Hydrochloride, Valacyclovir Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Agitation, Anaemia, Aspartate aminotransferase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>40</Age><Age Units>Year</Age Units><Indications>HERPES ZOSTER</Indications>	A 40-year-old male was hospitalized after experiencing agitation, anemia, and an increase in aspartate aminotransferase following the administration of carbamazepine, acetaminophen, tramadol hydrochloride, and valacyclovir hydrochloride for herpes zoster.
<Primary Suspect Drugs>Enoxaparin Sodium</Primary Suspect Drugs><Other Administered Drugs>Acebutolol Hydrochloride, Amlodipine Besylate, Cetirizine Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Abnormal sensation in eye, Cholestasis, Chronic kidney disease</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>62</Age><Age Units>Year</Age Units><Indications></Indications>	A 62-year-old male patient experienced adverse events including abnormal sensation in the eye, cholestasis, and chronic kidney disease after taking enoxaparin sodium, along with other administered drugs such as acebutolol hydrochloride, amlodipine besylate, and cetirizine hydrochloride, eventually resulting in hospitalization and death.
<Primary Suspect Drugs>Heparin Sodium</Primary Suspect Drugs><Other Administered Drugs>Clindamycin Hydrochloride, Econazole Nitrate, Floctafenine</Other Administered Drugs><Dose>40 MG (DAILY), SUBCUTANEOUS</Dose><Adverse Events>Eosinophilia, Hepatitis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>42</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 42-year-old male was hospitalized after experiencing eosinophilia and hepatitis believed to be caused by the administration of Heparin Sodium along with Clindamycin Hydrochloride, Econazole Nitrate, and Floctafenine for an ill-defined disorder at a daily subcutaneous dose of 40 MG.
<Primary Suspect Drugs>Venlafaxine Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Tramadol Hydrochloride</Other Administered Drugs><Dose>75 MG 2X PER 1 DAY</Dose><Adverse Events>Abdominal pain, Constipation, Volvulus</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>41</Age><Age Units>Year</Age Units><Indications>DEPRESSION</Indications>	A 41-year-old male was hospitalized after experiencing abdominal pain, constipation, and volvulus as adverse events after taking venlafaxine hydrochloride (75mg, twice a day) along with acetaminophen and tramadol hydrochloride for depression.
<Primary Suspect Drugs>Clarithromycin</Primary Suspect Drugs><Other Administered Drugs>Amoxicillin, Diclofenac Sodium, Hydroxychloroquine Sulfate</Other Administered Drugs><Dose></Dose><Adverse Events>Pruritus, Rash macular, Toxic skin eruption</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>53</Age><Age Units>Year</Age Units><Indications>GASTROINTESTINAL ULCER</Indications>	A female aged 53 experienced adverse events including pruritus, rash macular, and toxic skin eruption due to the administration of clarithromycin and other drugs. This led to hospitalization for the indication of gastrointestinal ulcer.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Clindamycin Hydrochloride, Econazole Nitrate, Enoxaparin Sodium</Other Administered Drugs><Dose></Dose><Adverse Events>Eosinophilia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>42</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 42-year-old male was hospitalized after taking tramadol hydrochloride and other administered drugs (clindamycin hydrochloride, econazole nitrate, and enoxaparin sodium) for unknown indications, leading to eosinophilia.
<Primary Suspect Drugs>Cefuroxime Sodium</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen; Codeine Phosphate, Clonazepam, Clonidine</Other Administered Drugs><Dose>750MG THREE TIMES PER DAY</Dose><Adverse Events>Agitation, Anxiety, Crying</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 69-year-old female was hospitalized after experiencing agitation, anxiety, and crying as adverse events following the administration of Cefuroxime Sodium along with Acetaminophen, Codeine Phosphate, Clonazepam, and Clonidine for an ill-defined disorder, with a dosage of 750MG three times per day.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Rofecoxib, Valdecoxib</Other Administered Drugs><Dose>50-100MG QDS ORAL</Dose><Adverse Events>Cardiac disorder, Chest pain, Dyspepsia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>52</Age><Age Units>Year</Age Units><Indications>ARTHRITIS, BACK PAIN</Indications>	A 52-year-old male was hospitalized after experiencing adverse events including cardiac disorder, chest pain, and dyspepsia, after taking Tramadol Hydrochloride along with other drugs Acetaminophen, Rofecoxib, and Valdecoxib for arthritis and back pain.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Norethindrone Acetate, Zolpidem Tartrate</Other Administered Drugs><Dose>2 TABLETS THREE TIMES DAILY</Dose><Adverse Events>Drug ineffective, Inadequate analgesia</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>54</Age><Age Units>Year</Age Units><Indications>ARTHRITIS, FIBROMYALGIA</Indications>	A 54-year-old female with arthritis and fibromyalgia was administered Tramadol Hydrochloride, Norethindrone Acetate, and Zolpidem Tartrate. However, the drug was ineffective and provided inadequate analgesia.
<Primary Suspect Drugs>Tiotropium Bromide</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Albuterol, Alendronate Sodium</Other Administered Drugs><Dose></Dose><Adverse Events>Pneumonia</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	The primary suspect drug of Tiotropium Bromide was administered along with other drugs (Acetaminophen, Albuterol, Alendronate Sodium), resulting in the adverse event of pneumonia and ultimately leading to the patient's death. The gender, age, age units, and indications were not provided.
<Primary Suspect Drugs>Morphine Sulfate</Primary Suspect Drugs><Other Administered Drugs>Etomidate, Fentanyl, Heparin Sodium</Other Administered Drugs><Dose>PATIENT-CONTROLLED ANALGESIA WITH BOLUS OF 1 MG WITH A LOCKOUT INTERVAL OF 5 MIN</Dose><Adverse Events>Drug effect decreased</Adverse Events><Outcomes></Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications>POSTOPERATIVE ANALGESIA</Indications>	The patient's primary suspect drugs were morphine sulfate, with other administered drugs being etomidate, fentanyl, and heparin sodium, and adverse events included decreased drug effect during patient-controlled analgesia for postoperative analgesia.
<Primary Suspect Drugs>Morphine Sulfate</Primary Suspect Drugs><Other Administered Drugs>Etomidate, Heparin Sodium, Isoflurane</Other Administered Drugs><Dose>PATIENT-CONTROLLED ANALGESIA WITH BOLUS OF 1 MG WITH A LOCKOUT INTERVAL OF 5 MIN</Dose><Adverse Events>Blood pressure increased, Drug effect decreased, Hyperhidrosis</Adverse Events><Outcomes></Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications>POSTOPERATIVE ANALGESIA</Indications>	The primary suspect drug in this report is Morphine Sulfate, which was administered along with Etomidate, Heparin Sodium, and Isoflurane. The patient received patient-controlled analgesia with a bolus of 1 mg, with a lockout interval of 5 minutes. The adverse events reported include increased blood pressure, decreased drug effect, and hyperhidrosis. The indication for administration was postoperative analgesia.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Completed suicide, Loss of consciousness</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>72</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 72-year-old female experienced adverse events of completed suicide and loss of consciousness, leading to death, after being administered Tramadol Hydrochloride for an unknown indication.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Prednisone, Ramipril, Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Cerebrovascular accident, Electrocardiogram repolarisation abnormality, Heart rate decreased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>64</Age><Age Units>Year</Age Units><Indications>RHEUMATOID ARTHRITIS</Indications>	A 64-year-old male with rheumatoid arthritis was hospitalized after experiencing a cerebrovascular accident, abnormal electrocardiogram repolarization, and decreased heart rate following administration of Tramadol Hydrochloride, Prednisone, and Ramipril.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Fluoxetine Hydrochloride, Olanzapine</Other Administered Drugs><Dose>100 MG   BID   ORAL</Dose><Adverse Events>Seizure</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>45</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 45-year-old female patient was hospitalized after experiencing a seizure following the administration of Tramadol Hydrochloride (100mg, BID, ORAL) along with Fluoxetine Hydrochloride and Olanzapine for pain relief.
<Primary Suspect Drugs>Morphine Sulfate</Primary Suspect Drugs><Other Administered Drugs>Etomidate, Heparin Sodium, Isoflurane</Other Administered Drugs><Dose>PATIENT-CONTROLLED-ANALGESIA WITH BOLUS OF 1 MG WITH A LOCKOUT INTERVAL OF 5 MIN; BOLUS IV</Dose><Adverse Events>Blood pressure increased, Drug effect decreased, Myocardial ischaemia</Adverse Events><Outcomes>RequiredIntervention</Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications>POSTOPERATIVE ANALGESIA</Indications>	The primary suspect drug in this ADE report is Morphine Sulfate, and other administered drugs include Etomidate, Heparin Sodium, and Isoflurane. The patient received a bolus of 1 mg of Morphine Sulfate through patient-controlled analgesia with a lockout interval of 5 minutes via IV. The adverse events reported were increased blood pressure, decreased drug effect, and myocardial ischemia. The outcome of the patient required intervention. The gender, age, age units, and indications were not specified in the report. The given indications for the drugs were postoperative analgesia.
<Primary Suspect Drugs>Morphine Sulfate</Primary Suspect Drugs><Other Administered Drugs>Etomidate, Fentanyl, Heparin Sodium</Other Administered Drugs><Dose>PATIENT-CONTROLLED ANALGESIA WITH BOLUS OF 1 MG WITH A LOCKOUT INTERVAL OF 5 MIN</Dose><Adverse Events>Drug effect decreased</Adverse Events><Outcomes>RequiredIntervention</Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications>POSTOPERATIVE ANALGESIA</Indications>	The primary suspect drug in this ADE report is Morphine Sulfate. Other administered drugs include Etomidate, Fentanyl, and Heparin Sodium. A dose of patient-controlled analgesia with a bolus of 1 mg and a lockout interval of 5 minutes was given. The adverse event reported is a decrease in drug effect. This led to the required intervention. The gender, age, and indications are not specified.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>50 MG</Dose><Adverse Events>Headache, Rash, Therapeutic response unexpected</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>BACK PAIN</Indications>	A female patient with back pain experienced headache, rash, and unexpected therapeutic response after administering 50mg of Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen</Other Administered Drugs><Dose></Dose><Adverse Events>Overdose</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	The primary suspect drug in this report was Tramadol Hydrochloride, with Acetaminophen also administered and the adverse event being overdose, resulting in death. The patient's gender was male and their age and indications were not provided.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Albuterol, Bisacodyl</Other Administered Drugs><Dose></Dose><Adverse Events>Rash</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>49</Age><Age Units>Year</Age Units><Indications></Indications>	A 49-year-old male experienced a rash after taking Tramadol Hydrochloride along with Acetaminophen, Albuterol, and Bisacodyl.
<Primary Suspect Drugs>Valdecoxib</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Rofecoxib, Tramadol Hydrochloride</Other Administered Drugs><Dose>10 MG (10 MG, 1 IN 1 D), ORAL</Dose><Adverse Events>Acute coronary syndrome, Dyspepsia, Gastritis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>52</Age><Age Units>Year</Age Units><Indications>ARTHRITIS</Indications>	A 52-year-old male patient taking Valdecoxib experienced adverse events such as acute coronary syndrome, dyspepsia, and gastritis, which resulted in hospitalization. Other administered drugs included Acetaminophen, Rofecoxib, and Tramadol Hydrochloride for the indication of arthritis.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Alendronate Sodium, Calcium Carbonate, Tramadol Hydrochloride</Other Administered Drugs><Dose>900 MG (300 MG, 3 IN 1 D), ORAL</Dose><Adverse Events>Confusional state, Dizziness, Dry mouth</Adverse Events><Outcomes>LifeThreatening</Outcomes><Gender>Female</Gender><Age>73</Age><Age Units>Year</Age Units><Indications>RHEUMATOID ARTHRITIS</Indications>	A 73-year-old female with rheumatoid arthritis experienced life-threatening adverse events, including confusional state, dizziness, and dry mouth, after taking gabapentin at a dose of 900 MG (300 MG, 3 IN 1 D) orally. Other administered drugs included alendronate sodium, calcium carbonate, and tramadol hydrochloride.
<Primary Suspect Drugs>Diclofenac Sodium</Primary Suspect Drugs><Other Administered Drugs>Budesonide; Formoterol Fumarate, Digitoxin, Esomeprazole Magnesium</Other Administered Drugs><Dose>50 MG DAILY</Dose><Adverse Events>Alanine aminotransferase increased, Anaphylactic shock, Aortic aneurysm</Adverse Events><Outcomes>Hospitalization, LifeThreatening</Outcomes><Gender>Female</Gender><Age>87</Age><Age Units>Year</Age Units><Indications>BACK PAIN</Indications>	The primary suspect drug was diclofenac sodium, and other drugs administered included budesonide, formoterol fumarate, digitoxin, and esomeprazole magnesium at a dose of 50 mg daily. The adverse events reported were increased alanine aminotransferase, anaphylactic shock, and aortic aneurysm resulting in hospitalization and life-threatening outcomes. The patient was a 87-year-old female, and the indication for treatment was back pain.
<Primary Suspect Drugs>Diclofenac Sodium</Primary Suspect Drugs><Other Administered Drugs>Felodipine, Glutamine, Simvastatin</Other Administered Drugs><Dose>75 MG/DAY</Dose><Adverse Events>Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood alkaline phosphatase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>NASOPHARYNGITIS</Indications>	A 69-year-old female was hospitalized due to an increase in alanine aminotransferase, aspartate aminotransferase, and blood alkaline phosphatase after being administered diclofenac sodium, felodipine, glutamine, and simvastatin for nasopharyngitis.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Droperidol, Fentanyl, Ketamine Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Multiple organ dysfunction syndrome</Adverse Events><Outcomes>LifeThreatening</Outcomes><Gender>Female</Gender><Age>53</Age><Age Units>Year</Age Units><Indications>POSTOPERATIVE ANALGESIA</Indications>	A 53-year-old female received Tramadol Hydrochloride for postoperative analgesia, along with Droperidol, Fentanyl, and Ketamine Hydrochloride. The patient experienced multiple organ dysfunction syndrome, resulting in life-threatening outcomes.
<Primary Suspect Drugs>Celecoxib</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Alendronate Sodium, Furosemide</Other Administered Drugs><Dose>200 MG (200 MG, 1 IN 1 D), ORAL</Dose><Adverse Events>Anaemia, Aortic stenosis, Bone marrow failure</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>85</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	An 85-year-old female patient experienced adverse events of anemia, aortic stenosis, and bone marrow failure after taking celecoxib, acetaminophen, alendronate sodium, and furosemide. These adverse events led to hospitalization. The drugs were administered orally, with a dose of 200 MG. The patient's gender is female and the primary indication for taking the drugs was pain.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Buprenorphine Hydrochloride; Naloxone Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Exposure during pregnancy, Premature labour</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>FIBROMYALGIA</Indications>	The primary suspect drug is Tramadol Hydrochloride, and other administered drugs include Acetaminophen, Buprenorphine Hydrochloride, and Naloxone Hydrochloride. Adverse events reported during pregnancy were exposure and premature labor. Hospitalization was the outcome for a male patient with the indication of Fibromyalgia.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>50 MG 2 Q 6HRS PM</Dose><Adverse Events>Drug effect decreased</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>BACK PAIN</Indications>	A female patient experienced decreased drug effect after taking Tramadol Hydrochloride for back pain with a 50 mg dose every 6 hours in the evening.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Ondansetron</Other Administered Drugs><Dose></Dose><Adverse Events>Bradycardia, Hypothermia</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>62</Age><Age Units>Year</Age Units><Indications></Indications>	A 62-year-old female experienced bradycardia and hypothermia after being administered Tramadol Hydrochloride and Ondansetron.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Ileus paralytic</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>POSTOPERATIVE ANALGESIA</Indications>	A female patient experienced ileus paralytic as an adverse event after being administered Tramadol Hydrochloride as postoperative analgesia.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amoxicillin; Clavulanate Potassium, Clavulanic Acid</Other Administered Drugs><Dose></Dose><Adverse Events>Hemiparesis, Muscular weakness, Tremor</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>27</Age><Age Units>Year</Age Units><Indications>CELLULITIS</Indications>	A 27-year-old male experienced hemiparesis, muscular weakness, and tremor after being administered Tramadol Hydrochloride for cellulitis, along with Amoxicillin and Clavulanate Potassium.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Agranulocytosis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A male patient was hospitalized due to agranulocytosis, possibly caused by Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose></Dose><Adverse Events>Dysuria, Urinary hesitation, Urinary retention</Adverse Events><Outcomes></Outcomes><Gender></Gender><Age></Age><Age Units></Age Units><Indications></Indications>	The primary suspect drug for this ADE report is Tramadol Hydrochloride, and the adverse events observed include dysuria, urinary hesitation, and urinary retention.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Bupropion Hydrochloride</Other Administered Drugs><Dose>50 MG 2 TID PRN</Dose><Adverse Events>Generalised tonic-clonic seizure, Loss of consciousness</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>47</Age><Age Units>Year</Age Units><Indications>BACK PAIN</Indications>	A 47-year-old male experienced a generalised tonic-clonic seizure and loss of consciousness after taking Tramadol Hydrochloride (50 MG 2 TID PRN) and Bupropion Hydrochloride for back pain.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Alcohol, Carisoprodol</Other Administered Drugs><Dose></Dose><Adverse Events>Completed suicide, Oedema, Pulmonary congestion</Adverse Events><Outcomes>Death</Outcomes><Gender>Male</Gender><Age>35</Age><Age Units>Year</Age Units><Indications>MUSCLE SPASMS, PAIN</Indications>	A 35-year-old male completed suicide after ingesting Gabapentin, Acetaminophen, Alcohol, and Carisoprodol. Adverse events included oedema and pulmonary congestion, resulting in death. The drugs were administered for the indications of muscle spasms and pain.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Citalopram Hydrobromide, Clonazepam, Ibuprofen</Other Administered Drugs><Dose>600 MG (300 MG, 2 IN 1 D), ORAL</Dose><Adverse Events>Anxiety, Cognitive disorder, Completed suicide</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>55</Age><Age Units>Year</Age Units><Indications>NEUROPATHY PERIPHERAL, POLYNEUROPATHY IDIOPATHIC PROGRESSIVE, RESTLESS LEGS SYNDROME</Indications>	A 55-year-old male took Gabapentin, Citalopram Hydrobromide, Clonazepam, and Ibuprofen orally at a dose of 600 MG, resulting in adverse events such as anxiety, cognitive disorder, and completed suicide, ultimately leading to death and hospitalization. The drugs were primarily used for neuropathy peripheral, polyneuropathy idiopathic progressive, and restless legs syndrome.
<Primary Suspect Drugs>Irbesartan</Primary Suspect Drugs><Other Administered Drugs>Alcohol, Nifedipine, Tramadol Hydrochloride</Other Administered Drugs><Dose>14 TABLETS OF IRBESARTAN 150 MG ON 08-APR-2005; TOTAL DURATION OF IRBESARTAN = 15 DAYS</Dose><Adverse Events>Blood pressure decreased, Hepatic failure, Overdose</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>45</Age><Age Units>Year</Age Units><Indications>HYPERTENSION</Indications>	A 45-year-old female with hypertension was hospitalized after experiencing decreased blood pressure, hepatic failure, and overdose following the administration of 14 tablets of Irbesartan 150 mg over a 15-day period, in addition to consuming Alcohol, Nifedipine, and Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>1 QID</Dose><Adverse Events>Dyspnoea</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>ARTHRALGIA, MARFAN'S SYNDROME</Indications>	A male patient experienced dyspnoea after being administered Tramadol Hydrochloride at a dose of 1 QID to treat arthralgia and Marfan's syndrome.
<Primary Suspect Drugs>Valproic Acid</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Amikacin Sulfate Liposome, Calcium Carbonate</Other Administered Drugs><Dose></Dose><Adverse Events>Coombs positive haemolytic anaemia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>65</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 65-year-old male patient was hospitalized due to Coombs positive hemolytic anemia after being administered valproic acid, acetaminophen, amikacin sulfate liposome, and calcium carbonate for unknown indications.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>50MG BID</Dose><Adverse Events>Drug effect decreased, Pain, Therapeutic response unexpected</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A female patient experienced decreased drug effect, pain, and an unexpected therapeutic response when orally administered Tramadol Hydrochloride at a dose of 50mg twice daily.
<Primary Suspect Drugs>Metronidazole</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Aspirin; Caffeine; Propoxyphene Hydrochloride, Ciprofloxacin Hydrochloride</Other Administered Drugs><Dose>500 MG (500 MG, DAILY INTERVAL: DAILY), ORAL</Dose><Adverse Events>Jaundice cholestatic</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>OPEN WOUND</Indications>	A male patient was hospitalized after taking Metronidazole, Acetaminophen, Aspirin, Caffeine, Propoxyphene Hydrochloride, and Ciprofloxacin Hydrochloride orally. They experienced cholestatic jaundice, and the drugs were administered for the indication of an open wound.
<Primary Suspect Drugs>Sulfasalazine</Primary Suspect Drugs><Other Administered Drugs>Acetylcysteine, Budesonide; Formoterol Fumarate, Cefuroxime Axetil</Other Administered Drugs><Dose>2000 MG (500 MG, 4 IN 1 D) ORAL</Dose><Adverse Events>Anaemia, Fatigue, Hepatitis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>64</Age><Age Units>Year</Age Units><Indications>RHEUMATOID ARTHRITIS</Indications>	A 64-year-old female with rheumatoid arthritis was administered sulfasalazine, acetylcysteine, budesonide, formoterol fumarate, and cefuroxime axetil orally, resulting in adverse events of anaemia, fatigue, and hepatitis, ultimately leading to hospitalization.
<Primary Suspect Drugs>Pantoprazole Sodium</Primary Suspect Drugs><Other Administered Drugs>Acetylcysteine, Cefuroxime Axetil, Formoterol Fumarate</Other Administered Drugs><Dose>40 MG, 1 TIME (S), SOME DF ORAL</Dose><Adverse Events>Anaemia, Antinuclear antibody positive, Hepatitis</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>64</Age><Age Units>Year</Age Units><Indications></Indications>	A 64-year-old female was hospitalized after taking Pantoprazole Sodium and experiencing adverse events including Anaemia, Antinuclear antibody positive, and Hepatitis. Other administered drugs included Acetylcysteine, Cefuroxime Axetil, and Formoterol Fumarate.
<Primary Suspect Drugs>Pantoprazole Sodium</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Aspirin; Caffeine; Propoxyphene Hydrochloride, Cetirizine Hydrochloride</Other Administered Drugs><Dose>40 MG 1X PER 1 DAY ORAL</Dose><Adverse Events>Cholestasis, Hepatocellular injury</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>65</Age><Age Units>Year</Age Units><Indications></Indications>	A 65-year-old male was hospitalized after experiencing cholestasis and hepatocellular injury possibly caused by the administration of Pantoprazole Sodium, Acetaminophen, Aspirin, Caffeine, Propoxyphene Hydrochloride, and Cetirizine Hydrochloride.
<Primary Suspect Drugs>Valdecoxib</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen; Propoxyphene Napsylate, Diltiazem Hydrochloride, Fentanyl Citrate</Other Administered Drugs><Dose>20 MG (20 MG, 1 IN 1 D), ORAL</Dose><Adverse Events>Blood pressure increased, Chills, Cold sweat</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>67</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 67-year-old female reported increased blood pressure, chills, and cold sweat after taking Valdecoxib (20mg, oral) for pain, along with other administered drugs including Acetaminophen, Propoxyphene Napsylate, Diltiazem Hydrochloride, and Fentanyl Citrate.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Calcium Carbonate, Cetirizine Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Cholestasis, Jaundice</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>65</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 65-year-old male was hospitalized after experiencing cholestasis and jaundice, possibly caused by the administration of Tramadol Hydrochloride along with Acetaminophen, Calcium Carbonate, and Cetirizine Hydrochloride, despite the unknown indication for drug use.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Acetaminophen; Propoxyphene Hydrochloride, Alprazolam</Other Administered Drugs><Dose></Dose><Adverse Events>Erythema</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 76-year-old female was hospitalized after experiencing erythema as an adverse event, possibly due to the administration of Tramadol Hydrochloride, Acetaminophen, Propoxyphene Hydrochloride, and Alprazolam for unknown indications.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Enalapril Maleate, Insulin Lispro (Human Analog), Ranitidine</Other Administered Drugs><Dose></Dose><Adverse Events>Hypoglycaemia</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>69</Age><Age Units>Year</Age Units><Indications>PAIN</Indications>	A 69-year-old female experienced hypoglycemia after taking Tramadol Hydrochloride for pain, along with Enalapril Maleate, Insulin Lispro (Human Analog), and Ranitidine.
<Primary Suspect Drugs>Rosiglitazone Maleate</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Ciprofloxacin Hydrochloride, Dimetindene</Other Administered Drugs><Dose>SUBCUTANEOUS</Dose><Adverse Events>Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood alkaline phosphatase increased</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>65</Age><Age Units>Year</Age Units><Indications></Indications>	The primary suspect drug in this ADE report is Rosiglitazone Maleate and the patient also received other administered drugs such as Acetaminophen, Ciprofloxacin Hydrochloride, and Dimetindene. The patient experienced adverse events including increased levels of Alanine aminotransferase, Aspartate aminotransferase, and Blood alkaline phosphatase. The outcome was hospitalization and the patient was a 65-year-old male.
<Primary Suspect Drugs>Amoxicillin; Clavulanate Potassium</Primary Suspect Drugs><Other Administered Drugs>Furosemide, Pantoprazole Sodium, Spiramycin</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Condition aggravated, Gastrointestinal ulcer perforation, Purpura</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>90</Age><Age Units>Year</Age Units><Indications></Indications>	A 90-year-old male experienced aggravated condition, gastrointestinal ulcer perforation, purpura, and required hospitalization after being administered Amoxicillin, Clavulanate Potassium, Furosemide, Pantoprazole Sodium, and Spiramycin orally.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Citalopram Hydrobromide, Clonazepam, Ibuprofen</Other Administered Drugs><Dose>600 MG (300 MG, 2 IN 1 D), ORAL</Dose><Adverse Events>Anxiety, Cognitive disorder, Completed suicide</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>55</Age><Age Units>Year</Age Units><Indications>NEUROPATHY PERIPHERAL, PAIN, RESTLESS LEGS SYNDROME</Indications>	A 55-year-old male took a 600 mg dose of gabapentin along with other drugs, including citalopram hydrobromide, clonazepam, and ibuprofen, orally. This resulted in adverse events such as anxiety, cognitive disorder, and completed suicide. The outcomes were death and hospitalization. The medications were initially taken to treat peripheral neuropathy, pain, and restless legs syndrome.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs></Other Administered Drugs><Dose>ONE AM , 2 PM ONE PRN</Dose><Adverse Events>Drug ineffective, Inadequate analgesia</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age>65</Age><Age Units>Year</Age Units><Indications>FIBROMYALGIA, PAIN</Indications>	A 65-year-old female with fibromyalgia and pain reported inadequate analgesia and drug ineffectiveness while taking Tramadol Hydrochloride at a dose of one in the morning, two in the afternoon, and one as needed.
<Primary Suspect Drugs>Acetaminophen; Propoxyphene Napsylate</Primary Suspect Drugs><Other Administered Drugs>Atenolol, Cyanocobalamin, Cyclobenzaprine Hydrochloride</Other Administered Drugs><Dose>1 TABLET  Q 8 HR PM  ORAL</Dose><Adverse Events>Agitation, Hallucination</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications>BACK PAIN</Indications>	A male patient with back pain and no specified age experienced agitation and hallucination after taking Acetaminophen, Propoxyphene Napsylate, Atenolol, Cyanocobalamin, and Cyclobenzaprine Hydrochloride. The adverse events led to hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Amitriptyline Hydrochloride, Furosemide, Lercanidipine</Other Administered Drugs><Dose></Dose><Adverse Events>Hyperhidrosis, Hypotension, Ileus paralytic</Adverse Events><Outcomes>Disability, Hospitalization</Outcomes><Gender>Female</Gender><Age>64</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 64-year-old female was hospitalized due to disability after taking Tramadol Hydrochloride, Amitriptyline Hydrochloride, Furosemide, and Lercanidipine. The adverse events experienced include hyperhidrosis, hypotension, and ileus paralytic, possibly caused by the unknown indication for drug use.
<Primary Suspect Drugs>Bupropion Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Death, Ill-defined disorder</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Female</Gender><Age>30</Age><Age Units>Year</Age Units><Indications>DEPRESSION</Indications>	A 30-year-old female taking Bupropion Hydrochloride for depression experienced death and ill-defined disorder, leading to hospitalization. She also received Tramadol Hydrochloride.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen; Propoxyphene Hydrochloride, Clonazepam, Diclofenac Sodium</Other Administered Drugs><Dose>2400 MG (DAILY), ORAL</Dose><Adverse Events>Back pain, Balance disorder, Condition aggravated</Adverse Events><Outcomes></Outcomes><Gender>Male</Gender><Age>60</Age><Age Units>Year</Age Units><Indications>NEUROPATHIC PAIN, NEUROSIS</Indications>	A 60-year-old male experienced back pain and balance disorder, which were aggravated by Gabapentin intake (2400 mg daily, oral). Other administered drugs include Acetaminophen, Propoxyphene Hydrochloride, Clonazepam, and Diclofenac Sodium for the indications of neuropathic pain and neurosis.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Bromazepam, Fluindione, Fluoxetine Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Confusional state, Hyponatraemia</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>81</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	An 81-year-old female was hospitalized after experiencing a confusional state and hyponatremia following the administration of Tramadol Hydrochloride, Bromazepam, Fluindione, and Fluoxetine Hydrochloride, for an unknown indication.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetylcysteine, Allopurinol, Bisoprolol Fumarate</Other Administered Drugs><Dose></Dose><Adverse Events>Gastrointestinal haemorrhage, International normalised ratio increased</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>76</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 76-year-old female died after taking Tramadol Hydrochloride, Acetylcysteine, Allopurinol, and Bisoprolol Fumarate for an unknown medical condition, experiencing gastrointestinal hemorrhage and an increased international normalized ratio.
<Primary Suspect Drugs>Oxycodone Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen; Propoxyphene Hydrochloride, Baclofen, Tramadol Hydrochloride</Other Administered Drugs><Dose>ORAL</Dose><Adverse Events>Body temperature increased, Confusional state, Hypertension</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>56</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 56-year-old male was hospitalized after taking Oxycodone Hydrochloride, Acetaminophen, Propoxyphene Hydrochloride, Baclofen, and Tramadol Hydrochloride orally for unknown reasons, resulting in increased body temperature, confusional state, and hypertension.
<Primary Suspect Drugs>Morphine Sulfate</Primary Suspect Drugs><Other Administered Drugs>Caffeine Citrate, Cyclobenzaprine Hydrochloride, Dextromethorphan Hydrobromide</Other Administered Drugs><Dose></Dose><Adverse Events>Accidental overdose</Adverse Events><Outcomes>Death</Outcomes><Gender>Female</Gender><Age>44</Age><Age Units>Year</Age Units><Indications></Indications>	A 44-year-old female accidentally overdosed on morphine sulfate and subsequently died, with caffeine citrate, cyclobenzaprine hydrochloride, and dextromethorphan hydrobromide being other administered drugs.
<Primary Suspect Drugs>Gabapentin</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Acetaminophen; Propoxyphene Napsylate, Alcohol</Other Administered Drugs><Dose></Dose><Adverse Events>Central nervous system mass, Completed suicide, Depression</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Male</Gender><Age>35</Age><Age Units>Year</Age Units><Indications>MUSCLE SPASMS</Indications>	A 35-year-old male experienced adverse events of a central nervous system mass, completed suicide, and depression after taking gabapentin, acetaminophen, acetaminophen with propoxyphene napsylate, and alcohol for muscle spasms, resulting in death and hospitalization.
<Primary Suspect Drugs>Baclofen</Primary Suspect Drugs><Other Administered Drugs>Buspirone Hydrochloride, Mirtazapine, Quetiapine Fumarate</Other Administered Drugs><Dose></Dose><Adverse Events>Agitation, Headache, Hyperhidrosis</Adverse Events><Outcomes>Hospitalization, RequiredIntervention</Outcomes><Gender>Male</Gender><Age>49</Age><Age Units>Year</Age Units><Indications></Indications>	A 49-year-old male experienced agitation, headache, and hyperhidrosis after taking Baclofen, Buspirone Hydrochloride, Mirtazapine, and Quetiapine Fumarate, leading to hospitalization and requiring intervention.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Citalopram Hydrobromide</Other Administered Drugs><Dose>50MG 1-2 DAILY.</Dose><Adverse Events>Balance disorder, Drug interaction, Gait disturbance</Adverse Events><Outcomes></Outcomes><Gender>Female</Gender><Age></Age><Age Units></Age Units><Indications>PAIN</Indications>	A female patient experiencing balance disorder, drug interaction, and gait disturbance after taking Tramadol Hydrochloride and Citalopram Hydrobromide at a dose of 50mg 1-2 times daily for pain.
<Primary Suspect Drugs>Alendronate Sodium</Primary Suspect Drugs><Other Administered Drugs>Amikacin Sulfate, Bromazepam, Calcium Carbonate</Other Administered Drugs><Dose></Dose><Adverse Events>Depressed level of consciousness, General physical health deterioration, Hypotension</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Female</Gender><Age>60</Age><Age Units>Year</Age Units><Indications></Indications>	A 60-year-old female experienced depressed level of consciousness, general physical health deterioration, and hypotension after taking Alendronate Sodium, Amikacin Sulfate, Bromazepam, and Calcium Carbonate, resulting in hospitalization and death as outcomes.
<Primary Suspect Drugs>Methylprednisolone</Primary Suspect Drugs><Other Administered Drugs>Furosemide, Levothyroxine Sodium, Omeprazole</Other Administered Drugs><Dose>8 MG (1 IN 1 D), ORAL</Dose><Adverse Events>Confusional state, Delirium</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>72</Age><Age Units>Year</Age Units><Indications>ILL-DEFINED DISORDER</Indications>	A 72-year-old female was hospitalized after experiencing a confusional state and delirium following the administration of Methylprednisolone, Furosemide, Levothyroxine Sodium, and Omeprazole for an ill-defined disorder.
<Primary Suspect Drugs>Esomeprazole Magnesium</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen; Propoxyphene Hydrochloride, Atenolol, Captopril</Other Administered Drugs><Dose></Dose><Adverse Events>Colitis, Diverticular perforation, Diverticulitis</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Female</Gender><Age>85</Age><Age Units>Year</Age Units><Indications></Indications>	A female aged 85 experienced adverse events including colitis, diverticular perforation, and diverticulitis after administration of Esomeprazole Magnesium, Acetaminophen, Propoxyphene Hydrochloride, Atenolol, and Captopril, resulting in hospitalization and death.
<Primary Suspect Drugs>Indapamide</Primary Suspect Drugs><Other Administered Drugs>Codeine Phosphate, Metoprolol Tartrate, Morphine Sulfate</Other Administered Drugs><Dose>2,5 MG (2,5 MG</Dose><Adverse Events>Blood creatine phosphokinase increased, Coma, Delirium</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>80</Age><Age Units>Year</Age Units><Indications></Indications>	An 80-year-old female was hospitalized after experiencing adverse events including increased blood creatine phosphokinase, coma, and delirium, potentially caused by the administration of indapamide, codeine phosphate, metoprolol tartrate, and morphine sulfate.
<Primary Suspect Drugs>Amikacin Sulfate</Primary Suspect Drugs><Other Administered Drugs>Alendronate Sodium, Amikacin Sulfate, Bromazepam</Other Administered Drugs><Dose></Dose><Adverse Events>Depressed level of consciousness, Hypotension, Lung disorder</Adverse Events><Outcomes>Death, Hospitalization</Outcomes><Gender>Female</Gender><Age>60</Age><Age Units>Year</Age Units><Indications>PYELONEPHRITIS ACUTE</Indications>	A 60-year-old female was administered Amikacin Sulfate, Alendronate Sodium, and Bromazepam for the treatment of acute pyelonephritis, resulting in adverse events including depressed level of consciousness, hypotension, and lung disorder. This led to death and hospitalization.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Tramadol Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Conjunctivitis, Migraine without aura</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age></Age><Age Units></Age Units><Indications></Indications>	A male patient was hospitalized after experiencing conjunctivitis and migraine without aura, possibly due to the administration of Tramadol Hydrochloride.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen</Other Administered Drugs><Dose></Dose><Adverse Events>Agitation, Cerebral atrophy, Confusional state</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Female</Gender><Age>77</Age><Age Units>Year</Age Units><Indications>DRUG USE FOR UNKNOWN INDICATION</Indications>	A 77-year-old female was hospitalized after experiencing adverse events of agitation, cerebral atrophy, and confusional state, possibly due to the administration of Tramadol Hydrochloride and Acetaminophen for an unknown indication.
<Primary Suspect Drugs>Tramadol Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen; Propoxyphene Hydrochloride, Aspirin, Diltiazem Hydrochloride</Other Administered Drugs><Dose></Dose><Adverse Events>Ileus paralytic, Intestinal obstruction, Vomiting</Adverse Events><Outcomes>Hospitalization</Outcomes><Gender>Male</Gender><Age>94</Age><Age Units>Year</Age Units><Indications></Indications>	A 94-year-old male was hospitalized due to adverse events, including ileus paralytic, intestinal obstruction, and vomiting, possibly caused by the administration of Tramadol Hydrochloride along with other drugs such as Acetaminophen, Propoxyphene Hydrochloride, Aspirin, and Diltiazem Hydrochloride.
<Primary Suspect Drugs>Metformin Hydrochloride</Primary Suspect Drugs><Other Administered Drugs>Acetaminophen, Acetaminophen; Propoxyphene Hydrochloride, Aspirin</Other Administered Drugs><Dose></Dose><Adverse Events>Diarrhoea, Renal failure, Vomiting</Adverse Events><Outcomes>Hospitalization, LifeThreatening</Outcomes><Gender>Female</Gender><Age>86</Age><Age Units>Year</Age Units><Indications>DIABETES MELLITUS NON-INSULIN-DEPENDENT</Indications>	An 86-year-old female with non-insulin-dependent diabetes mellitus experienced adverse events including diarrhea, renal failure, and vomiting after taking metformin hydrochloride along with acetaminophen, propoxyphene hydrochloride, and aspirin. This resulted in hospitalization and life-threatening outcomes.
